Notice of Application - 2010
[Federal Register: October 26, 2010 (Volume 75, Number 206)]
[Notices]
[Page 65658-65659]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26oc10-103]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 12 2010, Aldrich
Chemical Company Inc., DBA Isotec, 3858 Benner Road, Miamisburg, Ohio
45342-4304, made application by renewal to the Drug Enforcement
Administration (DEA) as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Methaqualone (2565) |
I |
| Ibogaine (7260) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| Psilocyn (7438) |
I |
| Normorphine (9313) |
I |
| Acetylmethadol (9601) |
I |
| Alphacetylmethadol except levo-
alphacetylmethadol (9603) |
I |
| Normethadone (9635) |
I |
| Norpipanone (9636) |
I |
| 3-Methylfentanyl (9813) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Phenylacetone (8501) |
II |
| 1-Piperidinocyclohexanecarbonitrile (8603) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine intermediate-A (9232) |
II |
| Meperidine intermediate-B (9233) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Dextropropoxyphene, bulk, (non-dosage
forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
The company plans to manufacture small quantities of the listed
controlled substances to produce isotope labeled standards for drug
testing and analysis.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 27, 2010.
Dated: October 19, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-27018 Filed 10-25-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
